跳至主要内容
临床试验/NCT03102502
NCT03102502已完成不适用

Study of the Effects of Enhanced External Counterpulsation on Vascular Hemodynamics and Status

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2017年3月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110
试验地点
1
主要终点
Change in blood flow velocity

研究概览

简要总结

The present study aimed to investigated the effect of Enhanced External Counterpulsation (EECP) on vascular hemodynamics and atherosclerosis, and the underlying shear stress related mechanisms

详细描述

Patients with coronary heart disease will be randomized into two groups: standard medical treatment and standard medical treatment plus EECP intervention. Hemodynamic parameters, vascular status and function will be measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • More than 50% stenosis of left main trunk and 3 epicardial coronary arteries and their large branches showed by coronary angiography
  • Or history of myocardial infarction
  • Or history of prior revascularization
  • Signed informed consent to participate in the study

排除标准

  • Clinically significant valvular heart disease
  • Aortic aneurysm
  • Congenital heart disease
  • Acute myocarditis
  • Arrythmias significantly interfere with the triggering of the EECP device
  • History of cerebral hemorrhage
  • Hemorrhagic disease
  • Lower limb infection, phlebitis
  • Deep venous thrombosis
  • Malignant disease
  • INR > 2.5
  • Uncontrolled hypertension, defined as SBP > 180mmHg or DBP > 110mmHg
  • Pregnancy

研究组 & 干预措施

Enhanced External Counterpulsation

Experimental

Patients receive a total of 35-36 hours of EECP treatment on top of guideline- driven standard medical therapy for coronary heart disease, 1-hour sessions every day over a 7-week period.

干预措施: EECP (Device)

Enhanced External Counterpulsation

Experimental

Patients receive a total of 35-36 hours of EECP treatment on top of guideline- driven standard medical therapy for coronary heart disease, 1-hour sessions every day over a 7-week period.

干预措施: Medical therapy (Drug)

Control

Active Comparator

Patients receive guideline- driven standard medical therapy for 7 weeks without Enhanced External Counterpulsation intervention.

干预措施: Medical therapy (Drug)

结局指标

主要结局

Change in blood flow velocity

时间窗: At baseline, during EECP and week 7 (post intervention)

Change from baseline in blood flow velocity measured by color Doppler ultrasound system

次要结局

  • Change in vascular endothelial function(At baseline and week 7 (post intervention))
  • Change in atherosclerosis(At baseline and week 7 (post intervention))

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yan Zhang

Associate Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验